ICAM-2/CD102 Recombinant antibody

ICAM-2/CD102 Uni-rAbTM Recombinant Antibody for IF/ICC, ELISA
Cat No. 84857-2-RR

产品说明书

CloneNo. 242237F8

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IF/ICC, ELISA

CD102, ICAM2, ICAM-2, ICAM 2, 242237F8

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive IF/ICC detected inHUVEC cells

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

84857-2-RR targets ICAM-2/CD102 in IF/ICC, ELISA applications and shows reactivity with human samples.

经测试应用 IF/ICC, ELISA Application Description
经测试反应性 human
免疫原 Recombinant protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 intercellular adhesion molecule 2
别名 CD102, ICAM2, ICAM-2, ICAM 2, 242237F8
计算分子量31kDa
GenBank蛋白编号NM_001099789.2
基因名称 ICAM2/CD102
Gene ID (NCBI) 3384
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDP13598
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

ICAM2 is a cell adhesion protein having important roles in cell migration, especially during inflammation when leukocytes cross the endothelium. Initially described as a receptor for lymphocyte function-associated antigen-1 (LFA1), ICAM2 may play a role in lymphocyte recirculation by blocking LFA-1-dependent cell adhesion. It mediates adhesive interactions important for antigen-specific immune response, NK-cell mediated clearance, lymphocyte recirculation, and other cellular interactions important for immune response and surveillance. ICAM2 has six N-linked glycosylation sites at amino acids (asparagines) 47, 82, 105, 153, 178 and 187.

实验方案

Product Specific Protocols
IF protocol for ICAM-2/CD102 antibody 84857-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...